Re: PFE’s huge emerging-markets business in branded generics
Some investors on Twitter and other venues were surprised to see that: i) branded generics (what PFE calls “Established Products”) comprised 53% of PFE’s overall sales in 1Q14; and ii) this business had a much higher profit margin than PFE’s branded-drug business.
These figures come from PFE’s 1Q14 PR:
For readers of this board, it should not be a revelation that branded generics are the future of Big Pharma :- ) See, for instance, #msg-66847124, #msg-61960596, and #msg-66595029.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”